Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma - Wikidata - wikimedia - TriplyDB

Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma

Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma

http://www.wikidata.org/entity/Q36014101

about

MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Advanced drug delivery systems for local treatment of the oral cavity Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.Emerging role of nanog in tumorigenesis and cancer stem cells.MicroRNAs: novel players in cancer diagnosis and therapies.Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy MicroRNAs as therapeutic targets in human cancers Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model.MicroRNAs in Liver Health and Disease Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.Targeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.Progress in microRNA delivery.Angiogenesis-related microRNAs in colon cancer.Current progress for the use of miRNAs in glioblastoma treatment.MicroRNAs: master regulators of drug resistance, stemness, and metastasis.The Multifunctional Protein Kinase C-ε in Cancer Development and Progression.MicroRNA and signaling pathways in gastric cancer.Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach.Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors.Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.Targeted nanoparticle for head and neck cancers: overview and perspectives.Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity.MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs.

P2860

Q26778591-5D1CDFA2-B119-473F-8895-BE84412A988C Q26997647-B5E3C9E9-63D8-4EB2-89A2-5F12EAECD87F Q27023295-6FE1BF49-023D-42F3-8E33-9D046A448E4C Q28078448-7C63C346-E59B-4D19-9A90-1BC6E15BFC62 Q28087186-87D41143-26E0-422E-AC5C-4C8166294693 Q28299698-A491AD3F-2578-464D-BBAC-31E3A78365C9 Q30420306-AB01F8FE-A518-4723-A4CB-6AEE4916C0A9 Q33786554-394A87E7-2F7A-4AAC-932D-8925DD13FCCB Q33914573-530FBEB5-5478-4421-8A25-F8E2B5FDC161 Q35647187-46D6CE68-3987-4ADD-8A26-47B96E115A13 Q35704420-2DF88E42-3883-469C-A2B4-56979FCA5D9F Q35860856-02A9EBEE-04C7-46C4-BD59-0591067C1B93 Q36029524-7B688087-5D45-4798-9232-4A29C0CB3B60 Q36070235-E6899331-6C51-4C87-AD65-70ECDB9FC9B7 Q36739805-A4092BC9-6B73-4CFB-BFF9-7B0E717E1416 Q37370429-ABA7F517-FE6A-4D6B-BB7A-DA8D888DDB67 Q37419338-280CAD94-788A-4B77-AEA2-A94D94506748 Q37478933-D20350AA-09D3-4A44-A0A8-52F1741FD9B6 Q38060849-A7B1BF2D-574B-484B-B441-4C380B065678 Q38102611-189D64FA-9735-401A-96D4-73ECCE21909E Q38186568-83B1648C-C550-4244-9470-099A4645B830 Q38204165-23701EEF-D4E9-4507-86CE-EF2F7453BA2D Q38233783-DBC6EC8F-F77C-4804-BB45-C5544822D90B Q38322466-42A071FA-88C5-4ADB-A71B-1FA5DA247387 Q38324456-2DB51880-38C0-4517-BF52-514262F04AB2 Q38645695-B68638EC-D419-4904-B9FE-4627F91EE242 Q38718535-AA4BDBEF-5B66-4935-8E13-459937A0C8C7 Q38719678-C4DC6E36-8A76-41E5-8D8B-6BD07A792ED0 Q38762983-ECBAB5F1-1A07-4048-9544-94ED0B95C804 Q38777547-BA8D4AFB-A9A5-4980-8410-AB7A14B7BBC6 Q38889859-8FD35380-9ABD-46E7-BB8E-85FF530EF2E1 Q39051391-0DB62EBE-44C5-420B-B46D-F8C3D690867B Q39181050-3292B89A-B5DD-4A40-A71A-93ADAD854FB2 Q39226270-8EFFCE4F-2059-4235-AC09-52EE928FBDF9 Q41457379-8CBD4754-F69A-4562-9B32-3E1080597C8D Q41920847-B1F68BED-3845-418B-81FF-FD37C6D02E33 Q43010589-DE51F268-F23C-491D-B336-99DC4D67FFC1 Q47370661-8F24504D-9DE5-4F24-BE8B-8C308ACEDF7E Q47664260-76C84287-9A96-49DD-9A56-D475C1C42763 Q47936792-884BD31E-B53E-48EB-9CF2-A55F9D06B878

P2860

Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma

http://www.wikidata.org/entity/Q36014101

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@ast

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@en

type

label

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@ast

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@en

prefLabel

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@ast

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@en

P1433

Q36014101-A399ED0D-C491-4E24-996B-9E55FFED8561

P1476

Q36014101-18D20C37-05F8-4A54-8553-4DF7B43AD15C

P2093

Q36014101-29EDA22E-E472-4B25-A7A8-9632C1AD35EC

Q36014101-3173F1DF-0DE2-4B27-8772-79E323E967B5

Q36014101-5CA41260-37FF-444A-B83B-218690A32423

Q36014101-7CDF1175-D02A-4404-AE50-7FD8DBA354A3

Q36014101-8E3F9C59-F88F-4A50-A2EF-09EC0C746826

Q36014101-9BC40D50-D3B0-411D-B593-6632EB180E82

Q36014101-AF8B2E5C-7F3F-45FE-AB91-B7479DCBA48B

Q36014101-BED6DE6A-4B4F-4C19-AFE2-20E10B0A4866

P2860

Q36014101-04DEB805-973F-4F31-AEEE-735AB2FDB52A

Q36014101-05F0B40E-3DEB-4F82-BC16-47B0C330C3A1

Q36014101-0772208E-0663-4E91-A068-C9FE03962A70

Q36014101-095E8838-AEED-4251-B541-C43C4E0C0521

Q36014101-0CAD6D62-A317-4F09-B67F-73717FB2E1E5

Q36014101-0F2CB761-F025-40CA-8638-9F87178EFD1D

Q36014101-0FAAE923-BC25-4B6D-BC4A-FAD055EAD2AF

Q36014101-11599692-E85A-409D-9AEC-47C40B156B75

Q36014101-11A1D23A-CB60-4F50-B637-BCCF0C4F41B0

Q36014101-198BF3F0-7A91-4ACE-A86B-AF5D208F8D7C

P304

Q36014101-7DE63E53-E15D-43CF-AD4E-11EBB4D7C202

P31

Q36014101-4C258459-2F93-47DC-9FA2-1AEF241E68A4

P356

Q36014101-B2D0E937-2D89-4542-989E-432E6E25C373

P433

Q36014101-A24DC1E7-E79E-4424-8F8C-616D7A6657F2

P478

Q36014101-9F74135A-D3F4-4052-A5F0-B4CEEF6830C0

P577

Q36014101-30C75D28-C8CC-47B7-A322-B7C40B09865F

P5875

Q36014101-B7596F85-19E2-4F56-BDAB-83B52CD1BC30

P698

Q36014101-AFBBA2FB-7703-4895-8428-2D317B134F7D

P921

Q36014101-06E78D89-7E1D-4314-BF03-3757D7C4D971

P932

Q36014101-713AF83D-8F3E-4B0F-A454-A71E497DB058

P356

P1433

Molecular Therapy

P1476

Lipid-based nanoparticle deliv ...... d neck squamous cell carcinoma

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jharna Datta

http://www.w3.org/2001/XMLSchema#string

Longzhu Piao

http://www.w3.org/2001/XMLSchema#string

Manchao Zhang

http://www.w3.org/2001/XMLSchema#string

Quintin Pan

http://www.w3.org/2001/XMLSchema#string

Theodoros N Teknos

http://www.w3.org/2001/XMLSchema#string

Tizhi Su

http://www.w3.org/2001/XMLSchema#string

Xiujie Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

MicroRNA signatures in human cancers

MicroRNA expression profiles classify human cancers

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Lysyl oxidase is essential for hypoxia-induced metastasis

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

Causes and consequences of microRNA dysregulation in cancer

let-7 regulates self renewal and tumorigenicity of breast cancer cells

PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility

P304

1261-1269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2012.67

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223972685

http://www.w3.org/2001/XMLSchema#string

P698

22491216

http://www.w3.org/2001/XMLSchema#string

P921

P932

3369300

http://www.w3.org/2001/XMLSchema#string